|1.||Popova, Nina K: 2 articles (11/2009 - 03/2002)|
|2.||Naumenko, Vladimir S: 1 article (11/2009)|
|3.||Kondaurova, Elena M: 1 article (11/2009)|
|4.||Tordera, R: 1 article (06/2003)|
|5.||Gray, K: 1 article (06/2003)|
|6.||Newson, M: 1 article (06/2003)|
|7.||Pei, Q: 1 article (06/2003)|
|8.||Sharp, T: 1 article (06/2003)|
|9.||Sprakes, M: 1 article (06/2003)|
|10.||Ivanova, Elena A: 1 article (03/2002)|
|1.||AIDS-Related Complex (ARC)
06/01/2003 - "Paroxetine (5 mg/kg s.c.) plus p-MPPI (8.5 mg/kg s.c.) also increased Arc mRNA but p-MPPI itself elevated Arc mRNA in many regions. "
06/01/2003 - "The present study tested the effect of different selective 5-HT(1A) receptor antagonists (WAY 100635, NAD-299, p-MPPI and LY 426965) in combination with a SSRI (paroxetine), on postsynaptic 5-HT function measured by increased expression of the immediate early gene, Arc. "
11/06/2009 - "5-HT(1A) receptor antagonist p-MPPI pretreatment (1 mg/kg i.p.) diminished hypothermia produced by centrally administered m-CPBG (40 nmol i.c.v.). "
03/29/2002 - "Similar p-MPPI (0.4 mg/kg) effects on ethanol-induced sleep and hypothermia were obtained in rats. "
05/01/1996 - "No hypothermia or reciprocal forepaw treading was produced by either drug when given at doses as high as 10 mg/kg. Neither p-MPPI nor p-MPPF (10 mg/kg) given alone significantly altered the ratio of 5-HIAA/5-HT in the hippocampus or striatum. "
05/01/1996 - "p-MPPI [4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido] ethylpiperazine] and p-MPPF [4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine] competitively antagonized 5-HT1A receptor activation in the rat, as measured by hypothermia, forepaw treading and 5-HT turnover; they exhibited to partial agonist activity on any of these measures. "
|3.||Mood Disorders (Mood Disorder)
10/23/1998 - "p-Chloroamphetamine-induced hyperglycemia was prevented by methysergide, which blocks the 5-HT1 and 5-HT2 receptor, the 5-HT1A/1B/2C receptor antagonist, (-)-propranolol, the selective 5-HT1A receptor antagonist, 4-(2'-methoxyphenyl-1-[2'-n-2"pyridinyl)-p-iodobenzamido]-ethyl-pi perazine (p-MPPI), the 5-HT2A/2B/2C receptor antagonists, ritanserin and 4-isopropyl-7-methyl-9-(2-hydroxy-1-methyl-propoxycarbonyl)-4,6A,7 ,8,9,10,10A-octahydro-indolo[4,3-FG]quinolone maleate(LY 53857). "
05/01/1998 - "Further, the 5-HT reuptake inhibitor fluoxetine, the 5-HT(1B/1C) receptor agonist TFMPP, the 5-HT synthesis inhibitor p-CPA, the selective 5-HT1A receptor antagonist p-MPPI, the 5-HT(1A/1B) receptor antagonist pindolol and the 5-HT3 receptor antagonist LY 278, 584 had no effect on NECA-induced catalepsy. "
|1.||5-HT1A Serotonin Receptor
|2.||Serotonin (5 Hydroxytryptamine)
|7.||5-HT3 Serotonin Receptors (5 HT3 Receptor)
|10.||Messenger RNA (mRNA)